Drug class
Non-anticholinergic smooth-muscle antispasmodic
Mechanism of action
Relaxes smooth muscle and reduces spasm. A proposed mechanism includes inhibition of catechol-O-methyltransferase (COMT)-related signalling and modulation of calcium-dependent contractile activity; the clinical mechanism is not completely established.
General use cases
- Symptomatic relief of painful smooth-muscle spasm of the gastrointestinal, biliary and urinary tracts where phloroglucinol-containing products are authorised.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
